Description
PROSTATE CANCER-SPECIFIC SEQUENCING SERVICES (RESEARCH STUDY SUPPORT)
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-06-15+$65,000= $65,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-06-15 | +$65,000 | $65,000 | PROSTATE CANCER-SPECIFIC SEQUENCING SERVICES (RESEARCH STUDY SUPPORT) |
Related awards · 7
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H5G9NWEFHXN4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E26D0017 | RPO EAST (36C24E) · B529 · SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $0 | FY2026 |
| VA24016C0010 | RPO EAST (36C24E) · AN41 · R&D- MEDICAL: HEALTH SERVICES (BASIC RESEARCH) | $0 | FY2016 |
Other recipients under B529 from RPO EAST (36C24E) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24E26N0114 | NEW YORK GENOME CENTER, INC. | RPO EAST (36C24E) | $19,590 | FY2026 |
| 36C24E26P0011 | NEW YORK GENOME CENTER, INC. | RPO EAST (36C24E) | $130,480 | FY2026 |
| 36C24E25N0039 | NEW YORK GENOME CENTER, INC. | RPO EAST (36C24E) | $26,020 | FY2025 |
| 36C24E24N0017 | NEW YORK GENOME CENTER, INC. | RPO EAST (36C24E) | $54,397 | FY2024 |
| 36C24E23N0010 | NEW YORK GENOME CENTER, INC. | RPO EAST (36C24E) | $82,470 | FY2023 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24E26N0145_3600_36C24E26D0017_3600 · retrieved 2026-09-26.